Larry Edelman — Boston Globe

BioTech

The Massachusetts biotech industry rebounded in 2024. Can the momentum last?

This column is from Trendlines, The Boston Globe’s business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to

Larry Edelman — Boston Globe January 9, 2025

BioTech

Dana-Farber blindsided Brigham and Women’s. The blowback will be strong

This column is from Trendlines, a business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to receive it

Larry Edelman — Boston Globe September 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Larry Edelman — Boston Globe

The Massachusetts biotech industry rebounded in 2024. Can the momentum last?

Dana-Farber blindsided Brigham and Women’s. The blowback will be strong

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe